National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
 Find Key Lab Scientists
 Training in NIAID Labs


Research Technologies
 About RTB
 Biological Imaging
 Genomic Technologies
 Flow Cytometry
 Protein Chemistry
  Mass Spectrometry
  Peptide Synthesis
  Protein Sequencing
   Technology
    Degradation
    Instruments
    N-Terminal Protein Sequencing
   Protocols
   Requests
   FAQs
 RML Research Technologies
 RTB Staff

Research Technologies Branch

Protein Sequencing Unit

Instruments

Applied Biosystems 494cLC procise protein sequencer (2) with four cartridge capability.

Both instruments are automated protein sequencers with online capillary liquid chromatography detection systems. Soluble samples, or samples blotted to polyvinylidene difluoride (PVDF), may be used for analysis. The sensitivity of these instruments is 50 to 100 fmoles. These instruments are used primarily to identify unknown samples and have sensitivity comparable to MS.

Applied Biosystems 494 HT protein sequencer with four cartridge capability.

This is an automated protein sequencer with online microbore LC detection. Soluble samples or samples, blotted to PVDF, may be used for analysis. The sensitivity of this instrument is 0.1 to 1 pmol. This instrument is used primarily for "quality control" or sequence verification.

Applied Biosystems 173A microblotter capillary LC system.

This is a fully integrated capillary LC sample preparation system that isolates and collects small amounts of sample in one step. As little as 500 fmol of sample may be prepared. Protein or peptide fractions collected with the 173A may be sequenced directly from the PVDF. The instrument can separate peptides that SDS gels cannot. If a protein is N-terminally blocked, or an internal sequence is needed, a gel plug containing the compound in question is subjected to enzymatic (e.g., trypsin) or chemical (e.g., CNBr) treatment, and then the peptides are eluted from the gel slice. They are then separated and blotted to PVDF by the 173A, enabling sequence analysis. N-terminal modification or blockage may be due to a formyl group, acetyl group, or other acyl grouping, or to the conversion of an N-terminal glutamine to pyroglutamine.

back to top


Contact Info

Mark K. Garfield
Phone: 301-435-3434
Fax: 301-480-2618
E-mail:
mg102k@nih.gov 
Mail:
Twinbrook I, Room 1013
5640 Fishers Lane 
Rockville, MD 20852

Search in Labs at NIAID
 
E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Contact Info

Mark K. Garfield
Phone: 301-435-3434
Fax: 301-480-2618
E-mail:
mg102k@nih.gov 
Mail:
Twinbrook I, Room 1013
5640 Fishers Lane 
Rockville, MD 20852